Skip to content

Webinar: Robust human iPSC-derived neuronal and glial in vitro drug discovery assays

By Isabel Onofre, PhD and Laura Calo, PhD

High-throughput in vitro assays to model neurodegeneration with human iPSC-derived neuronal and glial cells

Despite the great potential of human induced pluripotent stem cells (hiPSCs), technical and conceptual challenges for disease-specific assay validation often hinder their use during pre-clinical development.Ncardia has established large-scale manufacturing processes for hiPSC-derived neuronal sub-populations, microglia and astrocytes and has extensively characterized them using high-content imaging, multi-electrode arrays, flow-cytometry, and transcriptome analysis.

In this webinar, we show validated assays with co-culture of neurons, astrocytes and microglia in multiplexed and sensitive platforms where cell viability, autophagy, mitochondrial function, Ca2+ oscillations, endoplasmic reticulum stress and synaptic function can be perturbed to model neuro-pathological signatures.
These validated platforms provide ideal tools for the screening of novel therapeutic modalities against neurodegenerative pathologies.

Webinar
3646d8954fa815b8-400x0-0-files-Events-WEBINAR-Poster_Replay-Webinar-replay-Robust-hiPSC-derived-neuronal-and-glial-in-vitro-drug-discovery-assays-

Objectives:
In this webinar you will learn:

  1. The benefits and challenges of hiPSC-derived neuronal models
  2. How to describe the CNS pathophysiological changes associated with disease
  3. Optimized assays that recapitulate disease-specific phenotypes

Fill in the form below to watch the replay: